Biotech

ISS ESG InFocus: Pharmaceuticals & Biotechnology

September 9, 2022

ISS ESG’s team of specialist analysts release regular updates on the ESG risks associated with a specific industry. The InFocus reports focus on the ISS

Could Stem Cells Help End the Pandemic?

March 5, 2021

Below is an excerpt from ISS ESG’s thought leadership paper “Could Stem Cells Help End the Pandemic?” The full paper is available for download from

Financial Clarity Market Insights: Inflows to Healthcare and Biotech Funds

February 1, 2021

This week FC Market Insights looked at how the pandemic affected inflows to healthcare and biotech funds over the course of the last year. If

Biotech

ISS ESG InFocus: Pharmaceuticals & Biotechnology

Could Stem Cells Help End the Pandemic?

Financial Clarity Market Insights: Inflows to Healthcare and Biotech Funds

Search

ISS PRESS CENTER

NEWS & PR

CONTACT US

PRIVACY & LEGAL